Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
RNAC
$6.18
-3.59%
RNAC
· Cartesian Therapeutics, Inc.
$6.18
-0.23 (-3.59%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$193.94M
Shares
30.26M
Volume · Oct 23
85.81K
Avg daily vol (3M)
131.68K
All webcasts
Earnings call · FY2021 Q4
Cartesian Therapeutics, Inc. (RNAC) Q4 2021 Earnings Call
Revenue · derived Q4
$29.94M
+150.5% YoY
Net income · derived Q4
$12.24M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 10, 2022 · complete as-filed document
SEC periodic report
10-K report
Filed Apr 28, 2022 · complete as-filed document